[Uric acid metabolism and insulin resistance in type 2 diabetes].
D002318:Cardiovascular Diseases / Q000209:etiology; D002839:Chromans / Q000494:pharmacology / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology; D006801:Humans; D033461:Hyperuricemia / Q000188:drug therapy / Q000209:etiology; D007333:Insulin Resistance; D013844:Thiazoles / Q000494:pharmacology / Q000627:therapeutic use; D045162:Thiazolidinediones; D000077288:Troglitazone; D014527:Uric Acid / Q000378:metabolism*
D002839:Chromans; D013844:Thiazoles; D045162:Thiazolidinediones; D014527:Uric Acid; D000077288:Troglitazone